SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-23-078084
Filing Date
2023-09-20
Accepted
2023-09-20 17:28:43
Documents
1
Group Members
ALETA SHIFFBARRY SHIFF

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13D ea185515-13da2symetryx_neuba.htm SC 13D/A 79223
  Complete submission text file 0001213900-23-078084.txt   80996
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Subject) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82720 | Film No.: 231267271
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2828 BATHURST ST #400 TORONTO A6 M6B3A7
Business Address 2828 BATHURST ST #400 TORONTO A6 M6B3A7 4164537832
Symetryx Corp (Filed by) CIK: 0001991925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0531
Type: SC 13D/A